Gynecomastia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 11: | Line 11: | ||
===Prevalence=== | ===Prevalence=== | ||
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | *In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | ||
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | *The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | ||
Revision as of 19:34, 16 August 2017
|
Gynecomastia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gynecomastia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Gynecomastia epidemiology and demographics |
|
Risk calculators and risk factors for Gynecomastia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.
- The case-fatality rate of [disease name] is approximately [number range].
Age
- Gynecomastia has trimodal distribution.[1]
- The first peak is found in the neonatal period affecting 60-90 percent of all newborns. The second peak is during puberty and it declines in the late teenage years. The last peak is found in elderly with age ranging from 50-to-80-years olds.[2]
Race
- Gynecomastia has no racial predilection.[3]
Gender
- Gynecomastia is a benign male brest tissue proliferation.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Braunstein GD (1993). "Gynecomastia". N Engl J Med. 328 (7): 490–5. doi:10.1056/NEJM199302183280708. PMID 8421478.
- ↑ Johnson RE, Murad MH (2009). "Gynecomastia: pathophysiology, evaluation, and management". Mayo Clin Proc. 84 (11): 1010–5. doi:10.1016/S0025-6196(11)60671-X. PMC 2770912. PMID 19880691.
- ↑ Harlan WR, Grillo GP, Cornoni-Huntley J, Leaverton PE (1979). "Secondary sex characteristics of boys 12 to 17 years of age: the U.S. Health Examination Survey". J. Pediatr. 95 (2): 293–7. PMID 448573.